$CTMX - Power-play setup on another Biotech stock - Gapped up on strong volume on news of partnership with Moderna - Been tightening up. Broke above downtrend resistance on Mon. Inside-day bar on Tue
CTMX: CytomX Therapeutics, Inc. 2022-01-19 08:00:00 CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors
I am predicting a possible bullish run of over 300% given past historical data. When looking at the charts you’ll notice recurrent trends. First a price bearish downtrend that lasts a few months followed by a sudden 75% bullish run which is immediately followed by a sharp price dip of over 50%. Price action does culminate with a bullish run of 300%. The same...
Engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. Shareholders may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term...
high probability next target 7.94 if the price strongly breaks the horizontal white line and closes above high probability next target 10.60 if you need an analysis do not hesitate to contact me. don't forget to subscribe to receive updates if you find interesting what I do
The overall trend is down but recently strong bullish activity is happening. The share price shattered past the last stance of resistance around $11.50 and the last round of support is around $9.00. Can the bulls keep it up?
Looks good over 12. Has some resistance to get through at 13.50-14 area, but after that its pretty thin to the 20's.